title: A mixed adenoneuroendocrine carcinoma of the pancreas: a case report.
abstract: A tumor consisting of an adenocarcinoma component and a neuroendocrine carcinoma component, with each component accounting for at least 30% of the tumor, is defined as a mixed adenoneuroendocrine carcinoma (MANEC). We report a case of MANEC of the pancreas. A 63-year-old man presented with hyperglycemia and was referred to our hospital for further examination. Abdominal contrast-enhanced computed tomography (CT) revealed a mass of 2 cm in size in the pancreas head with portal vein narrowing. Fluorin-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) CT revealed increased accumulation in the mass of the pancreas head. Endoscopic retrograde cholangiopancreatography (ERCP) showed severe narrowing of the main pancreatic duct. Cytological analysis by endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) suggested a neuroendocrine tumor. Under the diagnosis of neuroendocrine tumor, pancreaticoduodenectomy with portal vein resection and regional lymph node dissection was performed with curative intent. Histological examination revealed that the tumor consisted of two cell populations. One was well- to moderately differentiated tubular adenocarcinoma. This cell component accounted for 45% of the whole tumor. The second component was non-adenocarcinoma cells arranged in a nest, and the cells had round nuclei, abundant cytoplasm, and coarse chromatin. The Ki67 labeling index was 40%. Immunohistochemically, the adenocarcinoma cells were positive for CEA but negative for chromogranin A (CgA) and synaptophysin (Syn), while the non-adenocarcinoma cells were positive for the expression of CgA and Syn but negative for CEA. Based on the findings, a diagnosis of MANEC of the pancreas was made. Postoperatively, lymph node metastasis and peritoneal dissemination developed rapidly and he died the 6 months after the operation. Due to the small number of reported cases of MANEC of the pancreas, its clinical behavior remains unclear and a standardized management protocol has not been established. Further investigation of more cases of this rare entity is necessary.
authors.affiliation: Department of Surgery, Chugoku Rousai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima, 737-0193, Japan.
authors.forename: Kouki
authors.initials: K
authors.lastname: Imaoka
authors.affiliation: Department of Surgery, Chugoku Rousai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima, 737-0193, Japan. safukuda@aol.com.
authors.forename: Saburo
authors.initials: S
authors.lastname: Fukuda
authors.affiliation: Department of Surgery, Chugoku Rousai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima, 737-0193, Japan.
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Tazawa
authors.affiliation: Department of Gastroenterology, Chugoku Rousai Hospital, Kure, Japan.
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Kuga
authors.affiliation: Department of Surgery, Chugoku Rousai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima, 737-0193, Japan.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Mochizuki
authors.affiliation: Department of Surgery, Chugoku Rousai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima, 737-0193, Japan.
authors.forename: Yuzo
authors.initials: Y
authors.lastname: Hirata
authors.affiliation: Department of Surgery, Chugoku Rousai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima, 737-0193, Japan.
authors.forename: Seiji
authors.initials: S
authors.lastname: Fujisaki
authors.affiliation: Department of Surgery, Chugoku Rousai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima, 737-0193, Japan.
authors.forename: Mamoru
authors.initials: M
authors.lastname: Takahashi
authors.affiliation: Department of Diagnostic Pathology, Chugoku Rousai Hospital, Hiroshima, Japan.
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Nishida
authors.affiliation: Faculty of Medicine, Hiroshima University, 1-2-3 Kasumi, Hiroshima, 734-8551, Japan.
authors.forename: Hideto
authors.initials: H
authors.lastname: Sakimoto